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Dissipation of Potassium and Proton Gradients Inhibits
Mitochondrial Hyperpolarization and Cytochrome c Release during
Neural Apoptosis
Monika Poppe,1 Claus Reimertz,1 Heiko Du¨ßmann,1 Aaron J. Krohn,1 C. Marc Luetjens,1 Doris Bo¨ckelmann,1
Anna-Liisa Nieminen,3 Donat Ko¨gel,1 and Jochen H. M. Prehn1,2
1Interdisciplinary Center for Clinical Research, Research Group “Apoptosis and Cell Death” and 2Department of
Pharmacology and Toxicology, Westphalian Wilhelms-University, D-48149 Mu¨nster, Germany, and 3Department of
Anatomy, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106
Exposure of rat hippocampal neurons or human D283 medul-
loblastoma cells to the apoptosis-inducing kinase inhibitor
staurosporine induced rapid cytochrome c release from mito-
chondria and activation of the executioner caspase-3. Mea-
surements of cellular tetramethylrhodamine ethyl ester fluores-
cence and subsequent simulation of fluorescence changes
based on Nernst calculations of fluorescence in the extracellu-
lar, cytoplasmic, and mitochondrial compartments revealed
that the release of cytochrome c was preceded by mitochon-
drial hyperpolarization. Overexpression of the anti-apoptotic
protein Bcl-xL, but not pharmacological blockade of outward
potassium currents, inhibited staurosporine-induced hyperpo-
larization and apoptosis. Dissipation of mitochondrial potas-
sium and proton gradients by valinomycin or carbonyl cyanide
p-trifluoromethoxy-phenylhydrazone also potently inhibited
staurosporine-induced hyperpolarization, cytochrome c re-
lease, and caspase activation. This effect was not attributable
to changes in cellular ATP levels. Prolonged exposure to vali-
nomycin induced significant matrix swelling, and per se also
caused release of cytochrome c from mitochondria. In contrast
to staurosporine, however, valinomycin-induced cytochrome c
release and cell death were not associated with caspase-3
activation and insensitive to Bcl-xL overexpression. Our data
suggest two distinct mechanisms for mitochondrial cyto-
chrome c release: (1) active cytochrome c release associated
with early mitochondrial hyperpolarization, leading to neuronal
apoptosis, and (2) passive cytochrome c release secondary to
mitochondrial depolarization and matrix swelling.
Key words: mitochondrial membrane potential; staurospor-
ine; valinomycin; potassium ionophore; proton ionophore;
Bcl-2; necrosis; hippocampal neurons; medulloblastoma cells
Mitochondria play a central role in both necrotic and apoptotic
neuron death by controlling cellular energetics, increasing the
production of reactive oxygen species, and releasing pro-
apoptotic factors into the cytosol (Murphy et al., 1999; Beal,
2000). The most prominent pro-apoptotic factor released from
mitochondria is cytochrome c (Liu et al., 1996). It is electrostat-
ically bound to the outer surface of the inner mitochondrial
membrane. After its release into the cytosol, cytochrome c is
capable of binding to the apoptotic protease-activating factor 1
(Apaf-1). This complex activates procaspase-9 in the presence of
deoxy-ATP (dATP), resulting in the activation of the caspase
cascade (Li et al., 1997; Zou et al., 1997). The release of cyto-
chrome c in apoptosis is controlled by Bcl-2 family proteins (Kim
et al., 1997; Kluck et al., 1997; Yang et al., 1997; Desagher and
Martinou, 2000).
An increase in mitochondrial outer membrane permeability is
required to trigger the release of cytochrome c. Several routes for
mitochondrial cytochrome c release have been proposed that
cause a selective outer membrane permeability increase (Schen-
del et al., 1998; Kluck et al., 1999; Shimizu et al., 1999). Another
theory proposes that the opening of the mitochondrial permeabil-
ity transition pore (PTP) stimulates the release of pro-apoptotic
factors (Zamzami et al., 1996; Lemasters et al., 1998; Marzo et
al., 1998; Vande Velde et al., 2000). The PTP complex is com-
posed of several proteins of the outer and inner mitochondrial
membrane, including the voltage-dependent anion channel
(VDAC) and the adenine nucleotide translocator (Zoratti and
Szabo, 1995; Bernardi and Petronilli, 1996; Beutner et al., 1996;
Nicolli et al., 1996). PTP opening could trigger cytochrome c
release indirectly by causing mitochondrial swelling and a subse-
quent rupture of the outer mitochondrial membrane.
Because PTP opening also results in inner membrane perme-
ability to protons, it is associated with a decrease in mitochondrial
transmembrane potential (DCm) (Zoratti and Szabo, 1995). De-
creases in DCm or sensitivity to PTP inhibitors have been re-
ported in several models of excitotoxic and apoptotic neuron
death (Nieminen et al., 1996; White and Reynolds, 1996; Wadia et
al., 1998; Heiskanen et al., 1999; Luetjens et al., 2000). However,
in many neuronal and non-neuronal apoptotic systems, cyto-
chrome c release occurred before a loss of DCm and proceeded in
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the presence of PTP inhibitors (Bossy-Wetzel et al., 1998; Yo-
shida et al., 1998; Krohn et al., 1999; Stefanis et al., 1999; Desh-
mukh et al., 2000; Goldstein et al., 2000). It has also been
reported that plasma membrane (Yu et al., 1996; Krohn et al.,
1999) and/or mitochondrial membrane hyperpolarization
(Vander Heiden et al., 1997; Kennedy et al., 1999; Scarlett et al.,
2000) may precede cytochrome c release and caspase activation
during survival factor withdrawal-, UV irradiation-, and
staurosporine-induced apoptosis. The present study demon-
strates the existence of two separate pathways of mitochondrial
cytochrome c release in neural cells that differ with respect to
changes in DCm, Bcl-xL sensitivity, and their ability to activate
the caspase cascade.
MATERIALS AND METHODS
Materials. Mitotracker Red (CMXRos) and tetramethylrhodamine ethyl
ester (TMRE) were purchased from Molecular Probes (Leiden, The
Netherlands). Rhodamine 123 (R123), valinomycin, and carbonyl cya-
nide p-trifluoromethoxy-phenylhydrazone (FCCP) were from Sigma
(Deisenhofen, Germany). Clofilium tosylate and tetraethylammonium
chloride (TEA) were from RBI Biotrend (Cologne, Germany). Stauro-
sporine, benzyloxycarbonyl-IETD-7-amido-4-trifluoromethylcoumarin
(z-IETD-AFC), and z-VDVAD-AFC were purchased from Alexis
(Gru¨nstetten, Germany). Acetyl-DEVD-7-amido-4-methylcoumarin
(Ac-DEVD-AMC) and Ac-LEHD-AMC substrates were from Bachem
(Heidelberg, Germany). All other chemicals were purchased in analytical
grade purity from Merck (Darmstadt, Germany).
Cell culture and transfection. Primary cultures of hippocampal neurons
were prepared from neonatal [postnatal day 1 (P1)] Fischer 344 rats as
described (Krohn et al., 1998). Dissected hippocampi were incubated for
20 min at 37°C in Leibovitz L-15 medium (Life Technologies, Karlsruhe,
Germany) containing 0.1% papain. Subsequently, the medium was re-
moved, and the cells were suspended by gentle trituration in MEM
medium supplemented with 10% NU R-serum, 2% B-27 supplement
(503 concentrate), 2 mM L-glutamine, 20 mM D-glucose, 26.2 mM sodium
bicarbonate, 100 U/ml penicillin, and 100 mg/ml streptomycin (Life
Technologies). The suspension was layered over medium containing 10
mg/ml trypsin inhibitor and centrifuged for 10 min at 600 rpm. The cells
were then resuspended, plated, and maintained in the above described
MEM culture medium at 37°C in an atmosphere of 95% air and 5%
carbon dioxide. For imaging studies, cells were grown on poly-L-lysine-
coated glass coverslips that had been placed into 35 mm Petri dishes
(Falcon Becton Dickinson, Heidelberg, Germany). For immunofluores-
cence microscopy experiments, cells were plated onto eight-well tissue
culture slides (Falcon Becton Dickinson). After 24 hr in vitro, cultures
were treated with the antiproliferation agent cytosine
b-arabinofuranoside (1 mM; Sigma). Experiments were performed on 8-
to 10-d-old cultures. Animal care followed official governmental
guidelines.
Human medulloblastoma D283 cells and breast adenocarcinoma
MCF-7/Casp-3 cells stably transfected with caspase-3 (Ja¨nicke et al.,
1998) were cultured in RMPI 1640 medium (Life Technologies) supple-
mented with penicillin (100 U/ml), streptomycin (100 mg/ml), and 10%
fetal calf serum (PAA, Co¨lbe, Germany). D283 cells originate from a
human cerebellar medulloblastoma and are positive for neurofibrillary
proteins, glutamine synthetase, and neuron-specific enolase (Vinoris et
al., 1994). D283 cells deficient in mitochondrial DNA were established
and cultured as described (Luetjens et al., 2000). For confocal laser-
scanning microscopy, cells were cultivated at least overnight in 150 ml of
medium on 35 mm glass-bottomed dishes (Willco BV, Amsterdam, The
Netherlands) coated with poly-L-lysine. For immunofluorescence micros-
copy experiments, cells were plated onto eight-well tissue culture slides.
In all other cases, cells were plated onto 6-, 24-,or 96-well tissue culture
plates (Nunc, Hamburg, Germany) or tissue culture flasks (Falcon Bec-
ton Dickinson).
For transfections, D283 and MCF-7/Casp-3 cells were plated onto 12.5
cm 2 culture flasks. One day later, cells were transfected with plasmids
cytochrome c-enhanced green fluorescent protein (EGFP) (Heiskanen et
al., 1999), pSFFV-Neo-Bcl-xL, or empty plasmid pSFFV-Neo (Boise et
al., 1993) using the F2 transfection reagent (Targeting Systems, Santee,
CA). Five micrograms of DNA and 5 ml of F2 reagent were diluted in 2.5
ml RPMI medium under serum-free conditions and incubated at 37°C for
20 min. Then cultures were incubated with the DNA-F2-transfection
mixture at 37°C for 2 hr. Cells were cultured overnight in RPMI medium
containing 10% fetal calf serum. For generation of stable cell lines,
transfected MCF-7/Casp-3 cells containing cytochrome c–EGFP were
selected in the presence of 1 mg/ml G418 for 2 weeks, and clones
expressing mitochondrial cytochrome-EGFP were enriched. Expression
of cytochrome c–EGFP was verified by Western blot analysis as de-
scribed below using antibodies against GFP (Clontech, Heidelberg, Ger-
many) and cytochrome c (Heiskanen et al., 1999). Cytochrome c–EGFP-
positive cells were routinely checked for colocalization of cytochrome c
with 50 nM CMXRos as mitochondrial marker. D283 cells stably over-
expressing Bcl-xL were selected in the presence of 500 mg/ml G418 for 2
weeks. Expression of Bcl-xL was analyzed by Western blot analysis as
described below.
TMRE-based detection of changes in mitochondrial transmembrane po-
tential (DCm). TMRE is a cationic, membrane-permeant dye that accu-
mulates in the negatively charged mitochondrial matrix according to the
Nernst equation potential (Ehrenberg et al., 1988). Estimation of DCm in
cultured rat hippocampal neurons was performed essentially as described
previously (Krohn et al., 1999). Briefly, cells were treated with stauro-
sporine (300 nM) or vehicle (dimethylsulfoxide) for the indicated period
of time and incubated with 100 nM TMRE for 15 min at room temper-
ature in HEPES-buffered saline (HBS) (in mM: 144 NaCl, 10 HEPES, 2
CaCl2, 1 MgCl2, 5 KCl, and 10 D-glucose; 320 mOsm, pH 7.4). The dye
was present in the buffer during data collection. TMRE fluorescence was
measured with a fluorescence microscope (Eclipse TE 300 inverted-stage
microscope; Nikon, Du¨sseldorf, Germany) and a 403 S-fluorescence
objective. Optics were as follows: excitation, 540–580 nm; dichroic mir-
ror, 595 nm; and emission, 600–660 nm. Digital images of equal exposure
were acquired using a 12-bit digital CCD camera (Visicam; Visitron,
Munich, Germany) and Metamorph software (Universal Imaging Coop-
eration, West Chester, PA). Fluorescence data, which reflect the average
pixel intensity obtained from the neuronal soma excluding the nucleus,
are expressed in arbitrary fluorescence units (AU). Background fluores-
cence was subtracted from the values.
In the experiments shown in Figure 1b, hippocampal neurons were
treated with 300 nM staurosporine (STS) or vehicle for 6 hr. Subse-
quently, cells were incubated for 15 min in HBS or modified HBS
containing 25 mM TEA, 1 mM clofilium tosylate, 120 mM NaCl, 10 mM
HEPES, 2 mM CaCl2, 1 mM MgCl2, 5 mM KCl, and 10 mM D-glucose.
Cells were loaded with 100 nM TMRE for 10 min, and TMRE fluores-
cence was acquired and analyzed as described above.
TMRE uptake of human D283 medulloblastoma cells in response to
STS was quantified by confocal laser-scanning microscopy using an in-
verted Olympus IX70 microscope equipped with a confocal laser-
scanning unit and a 603 oil immersion objective (Fluoview, Olympus,
Hamburg) as described previously (Luetjens et al., 2000). After detection
of autofluorescence, 10 or 100 nM TMRE was added to the cultures.
TMRE was excited with the 488 nm line, and emission was detected from
a 0.63-mm-thick optical section with a 565 nm long-pass filter. Whole
cellular fluorescence after background subtraction was calculated using
the UTHSCSA ImageTool program (developed at the University of
Texas Health Science Center at San Antonio, TX; available from the
Internet by anonymous FTP from www.maxrad6.uthscsa.edu).
Simulation of changes in cellular TMRE fluorescence based on Nernst
calculations of fluorescence in the extracellular, cytoplasmic, and mito-
chondrial compartments was performed as described previously (Ward et
al. 2000). The following constants were used: (1) mitochondrial volume
fraction: 2%. To estimate the mitochondrial volume, areas defined as
mitochondria by TMRE fluorescence intensity were integrated from 40
scans with 0.47-mm-thick confocal sections and 0.5 mm intervals in
TMRE-stained D283 cells. Mitochondria in neuronal cells are rod-
shaped with an average diameter of 0.25 mm and an average length of 1
mm (Jacobson, 1972; Trimmer et al. 2000). Blurring of an artificial image
of mitochondria-like structures using the microscope point spread func-
tion revealed a threefold overestimation. The mitochondrial volume
fraction used for the simulation was therefore less than the confocally
measured mitochondrial volume fraction (6%). The volume of the so-
mata were integrated from optical sections of the same cells after
addition of 5 mM oligomycin and 2 mM FCCP. (2) Permeability constant
for the equilibration across the plasma membrane: 1 6 0.1% sec 2 1. The
constant was calculated from the slope of the fluorescence intensity decay
in the somata of TMRE-stained cells after addition of 2 mM FCCP and
5 mM oligomycin. (3) Saturation constant: 700 mM. The saturation con-
centration of TMRE was evaluated by adding 10, 30, 50, 100, 150, 250,
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and 500 nM TMRE to D283 cells. The measured fluorescence intensity of
mitochondria-rich regions after cytoplasmic background subtraction at
each concentration after equilibration was fitted to a sigmoidal Boltz-
mann equation to calculate the saturation concentration. The calculated
saturation concentration of D283 medulloblastoma cells is higher than
the published saturation concentration of primary neurons (Ward et al.,
2000), suggesting an increased quench threshold and/or the existence of
additional cellular processes that regulate TMRE distribution in trans-
formed cells. (4) External probe concentration: 10 or 100 nM TMRE.
Plasma and mitochondrial membrane potential changes were simulated
as indicated.
Use of alternative probes to detect changes in DCm. R123, like TMRE,
is a cationic, voltage-sensitive probe that reversibly accumulates in mi-
tochondria (Emaus et al., 1986) and that was used in the present study as
a second probe to detect changes in DCm. Cells were loaded with 100
nM–2 mM R123 in medium for 30 min at 37°C. Subsequently, cultures
were washed with R123-free HBS, and R123 fluorescence was monitored
by epifluorescence microscopy as described above.
For immunocytochemistry experiments and as a third probe to detect
changes in DCm, we used the voltage-sensitive probe CMXRos
(Zamzami et al., 1996). In contrast to TMRE and R123, CMXRos forms
stable thiol conjugates with mitochondrial proteins, inhibiting release of
the dye from mitochondria and enabling fixation of cells while retaining
the dye (Krohn et al., 1999). Cells were treated with valinomycin,
staurosporine, or vehicle. For fluorescence microscopy, cells were incu-
bated with 50 nM CMXRos during the last 15 min of the exposure.
CMXRos-stained cells were fixed using methanol–acetic acid (3:1) for
15 min at 220°C and washed with PBS. Fluorescence was observed using
an Eclipse TE 300 inverted microscope and a 403 dry or 1003 oil
immersion objective with the following optics: excitation, 510–560 nm;
dichroic mirror, 575 nm; and emission, .590 nm. Digital images of equal
exposure were acquired with a SPOT-2 camera (Diagnostic Instruments,
Sterling Heights, MI) using Spot software version 2.21 (Diagnostic
Instruments).
To exclude the possibility that fluorescence signal changes were caused
by alterations in cell morphology, TMRE and CMXRos uptakes were
also quantified in cell lysates. In the case of TMRE, cells were treated
with 100 nM TMRE at 37°C for 10 min after the exposure to STS.
Medium was discarded, and cells were lysed in lysis buffer (2% SDS, 0.1
M Tris, pH 7.5). Fluorescence was measured using an HTS fluorescence
plate reader (Perkin-Elmer, Langen, Germany) (excitation, 577 nm;
emission, 595 nm). In the case of CMXRos, D283 cells were loaded with
100 nM CMXRos during the last 15 min of exposure, washed with HBS,
and fluorescence was measured using the above-mentioned fluorescence
plate reader (excitation 590 nm, emission 635 nm). Protein content per
well was determined with the Pierce Micro-BCA Protein assay Kit
(KMF, Cologne, Germany). TMRE or CMXRos fluorescence were
expressed as fluorescence units per microgram of protein. As a positive
control, cultures were exposed to the protonophore FCCP (10 mM).
Exposure to FCCP decreased CMXRos uptake from 55.8 6 2.5 AU/mg
of protein in vehicle-treated controls to 37.4 6 4.2 AU/mg of protein in
cultures treated for 30 min with FCCP ( p , 0.05; n 5 8 cultures per
treatment).
Determination of the cell viabilit y and Hoechst staining. Cells were
simultaneously stained with 1 mM calcein AM and 2 mM ethidium ho-
modimer (EthD-1) in serum-free medium using the LIVE/DEAD Via-
bility/Cytotoxicity Kit (Molecular Probes). Calcein AM is converted to
intensely green fluorescent calcein in metabolically active cells through
the activation of intracellular esterases. EthD-1 is a DNA-binding dye
that enters dead cells through damaged membranes. Calcein and EthD-1
fluorescence were observed using the above-mentioned inverted micro-
scope and a 203 dry immersion objective with the following optics: for
calcein, excitation, 465–495 nm; dichroic mirror, 505 nm; emission,
515–555 nm; for EthD-1, excitation, 510–560 nm; dichroic mirror, 575
nm; emission, .590 nm. Digital images were acquired as described
above. A total of 430–3000 cells were counted per culture. Chromatin
condensation and fragmentation were visualized using the DNA-binding
fluorescent dye Hoechst 33258 (Sigma). Cells cultured on coverslips were
fixed in methanol–acetic acid (3:1) for 15 min at 220°C. Cells were
washed in PBS and incubated in PBS containing 1 mg/ml Hoechst 33258
for 20 min at room temperature. Nuclei were observed using the Eclipse
TE 300 inverted microscope and a 203 dry immersion objective with the
following optics: excitation, 340–380 nm; dichroic mirror, 400 nm; and
emission, 435–485 nm. A total of 700–800 nuclei were counted per
culture.
Immunofluorescence analysis. For immunofluorescence analysis, cells
were fixed on eight-well tissue culture slides, washed three times with
PBS, permeabilized at 4°C for 3 min in PBS containing 0.1% Triton
X-100, and then incubated with blocking solution (PBS with 5% horse
serum and 0.3% Triton X-100) for 30 min at room temperature. Cyto-
chrome c was detected using a monoclonal anti-cytochrome c antibody
(clone 6H2.B4; PharMingen Becton Dickinson) that recognizes the na-
tive form of cytochrome c. The antibody was used at a concentration of
1:1000 in PBS containing 1% horse serum and 0.3% Triton X-100. After
incubation at room temperature for 2 hr, cells were washed twice with
PBS and incubated with biotin-conjugated anti-mouse IgG antibody
(Vector Laboratories, Burlingame, CA) diluted 1:500. The secondary
antibody was detected using Oregon green-conjugated streptavidin (Mo-
lecular Probes) diluted 1:1000 in PBS for 20 min at room temperature.
Epifluorescence microscopy was performed as described above.
Digital imaging of EGFP-tagged cytochrome c. Cytochrome c–EGFP
Figure 1. Staurosporine induces hyperpolarization of rat hippocampal
neurons. a, Cultured rat hippocampal neurons exposed to STS for the
indicated period of time were loaded with TMRE (100 nM, 15 min), and
fluorescence was quantified. The TMRE uptake increased significantly at
all time points measured. Data are means 6 SEM from n 5 27–150
neurons from n 5 5–20 separate experiments per time point. Different
from controls *p , 0.05. b, STS-induced increase in TMRE fluorescence
was not inhibited by blocking outward potassium currents. Hippocampal
neurons were treated with 300 nM STS for 6 hr. Subsequently, cultures
were exposed to HBS or HBS 1 TEA 1 clofilium tosylate (Clo) for a
further 15 min. After a 10 min loading period, cellular TMRE fluores-
cence was acquired. Data were not expressed as an SD and therefore were
presented in median/quartile form and represent values from n 5 82–185
cells. *,#p , 0.05 compared with respective controls.
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expressing cells were cultivated for at least 1 d in 150 ml of medium on
35 mm glass-bottomed dishes (Willco BV) coated with poly-D-lysine to
let them attach firmly. EGFP fluorescence was observed using the Eclipse
TE 300 inverted microscope and a 1003 oil immersion objective
equipped with the appropriate filter set. Digital images were acquired
with the SPOT-2 camera described above. For time-lapse images, dishes
were mounted onto the microscope stage. In control experiments, the
cytochrome c signal could be monitored for up to 24 hr. The cells were
stimulated with 3 mM staurosporine or 10 mM valinomycin or the combi-
nation of both directly on the stage after acquiring the first image. The
media was enriched with 10 mM HEPES and thoroughly mixed to ensure
a proper distribution of the drugs. To prevent evaporation, the media was
covered with embryo-tested paraffin-oil (Sigma).
Measurement of caspase-3-like protease activity. After treatment with
valinomycin, staurosporine, FCCP, or vehicle, cells were lysed in 200 ml
of lysis buffer [10 mM HEPES, pH 7.4, 42 mM KCl, 5 mM MgCl2, 1 mM
phenylmethylsulfonyl fluoride (PMSF), 0.1 mM EDTA, 0.1 mM EGTA, 1
mM dithiothreitol (DTT), 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 5
mg/ml aprotinin, and 0.5% 3-(3-cholamidopropyldimethylammonio)-1-
propane sulfonate (CHAPS)]. Fifty microliters of this lysate were added
to 150 ml of reaction buffer [25 mM HEPES, 1 mM EDTA, 0.1% CHAPS,
10% sucrose, 3 mM DTT, pH 7.5 and 10 mM of the respective caspase
substrate (Ac-DEVD-AMC, Ac-LEHD-AMC, z-IETD-AFC, or
z-VDVAD-AFC)]. Accumulation of AMC or AFC fluorescence was
monitored over 120 min using an HTS fluorescent plate reader (excita-
tion, 380 nm; emission, 465 nm). Fluorescence of blanks containing no
cell lysate were subtracted from the values. Protein content was deter-
mined using the Pierce Coomassie Plus Protein Assay Reagent (KMF).
Caspase activity is expressed as change in fluorescent units per micro-
gram of protein per hour.
Subcellular f ractionation and immunoblotting. D283 cells from one 175
cm 2 flask were collected at 200 3 g for 5 min and washed with PBS. The
cell pellet was resuspended in 100 ml of buffer A (20 mM HEPES–KOH,
pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 250 mM
sucrose, 100 mM PMSF, 1 mg/ml pepstatin A, 2 mg/ml leupeptin, and 2
mg/ml aprotinin). Cells were homogenized using a glass dounce and a
“tight” pestle (10 strokes). Cell homogenates were centrifuged at
15,000 3 g for 15 min at 4°C. The obtained pellet represented the
mitochondria-containing nuclear–heavy membrane fraction. The super-
natant was respun for a further 15 min at 20,000 3 g at 4°C. This second
supernatant represented the cytosol (including the light membrane frac-
tion; Ellerby et al., 1997). Thirty micrograms of protein was loaded onto
a 15% SDS-polyacrylamide gel. Proteins were separated for 1 hr at 120 V
and then blotted to nitrocellulose membranes (Protean BA 83; 2 mm;
Schleicher & Schuell, Dassel, Germany) in Towbin-buffer [25 mM Tris,
192 mM glycine, 20% methanol (v/v) and 0.01% SDS] at 15 V for 45 min.
The blots were blocked with 5% nonfat milk in TBST (15 mM Tris-HCl,
pH 7.5, 200 mM NaCl, and 0.1% Tween 20) for 2 hr at room temperature.
Membranes were incubated with a mouse monoclonal anti-cytochrome c
antibody (clone 7H8.2C12; 1:1000; PharMingen Becton Dickinson), a
mouse monoclonal anti-VDAC antibody (31HL; 1:1000; Calbiochem,
Bad Soden, Germany) to exclude contamination of cytoplasmic extracts
with mitochondria, or a mouse monoclonal anti-a-tubulin antibody
(clone DM 1A; 1:1000; Sigma) to prove equal loading of the samples. For
caspase-3 immunoblots, 30 mg of protein of whole-cell lysate (lysis buffer:
68.5 mM Tris/HCl, pH 6.8, 2% SDS, and 10% glycerol) were loaded onto
a 15% SDS-polyacrylamide gel. After blotting, membranes were probed
with a rabbit polyclonal anti-caspase 3 antibody (H277; 1:500; Santa
Cruz, Heidelberg, Germany). For detection of Bcl-xL expression, mem-
branes were probed with a rabbit polyclonal anti-Bcl-x antibody diluted
1:1000 (kindly provided by Prof. Craig B. Thompson, University of
Pennsylvania). Antibodies were diluted in blocking solution, and blots
were incubated overnight at 4°C. Primary antibodies were detected using
horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit an-
tibodies (Promega, Heidelberg, Germany) used 1:5000 in blocking solu-
tion for 1 hr at room temperature. The blots were developed using the
Pierce SuperSignal substrate chemiluminescence reagent.
Determination of cellular ATP. ATP was determined using the ATP
Bioluminescence Assay Kit CLS II (Boehringer Mannheim, Mannheim,
Germany). Cells cultivated on six-well tissue culture plates were col-
lected at 10,000 rpm for 2 min at 4°C and washed with PBS. The cell
pellet was resuspended in 50 ml of ice-cold ATP-lysis buffer (100 mM Tris
and 4 mM EDTA, pH 7.75), 150 ml of boiling ATP-lysis buffer was added,
and samples were incubated for 2 min at 99°C. Cell lysates were centri-
fuged at 10,000 rpm for 1 min at 4°C, and supernatants were collected.
ATP measurement was performed using 50 ml of supernatant and 50 ml
of luciferase reagent. After a 20 sec delay the chemiluminescence was
measured with 2 sec integration time in a lumi-imager (Boehringer
Mannheim). Protein content was determined using the Roti-Quant pro-
tein assay (Roth, Karlsruhe, Germany). Luciferase activity was expressed
as fluorescent units per microgram of protein. Cultures treated with
vehicle were set to 100% activity.
Statistics. Data are given as means 6 SEM. For statistical comparison,
t test or one-way ANOVA followed by Tukey test were used. Data that
were not measured as SDs are presented as medians/quartiles and were
analyzed by Kruskal–Wallis H test and subsequent Bonferroni-corrected
Mann–Whitney U test. P values ,0.05 were considered to be statistically
significant.
RESULTS
Exposure of cultured rat hippocampal neurons to
staurosporine induces early
membrane hyperpolarization
Exposure to the protein kinase inhibitor staurosporine induces
apoptosis in cultured rat hippocampal neurons (Prehn et al.,
1997). We have previously demonstrated that mitochondrial de-
polarization is not required for cytochrome c release and caspase
activation in this model (Krohn et al., 1999). Mitochondria re-
mained polarized and could be depolarized by addition of the
protonophore FCCP at a time point when cytochrome c was
released and the caspase cascade was maximally activated. On the
contrary, an increased uptake of TMRE into mitochondria could
be observed during the staurosporine exposure. We exposed
cultured rat hippocampal neurons to 300 nM staurosporine and
detected a significant increase in TMRE uptake 2 hr after onset
of the treatment (Fig. 1a). By 8 hr, 73 6 2.7% of the STS-treated
hippocampal neurons had released their cytochrome c, as evi-
denced by a transition from a punctate to a diffuse cytochrome c
immunofluorescence (n 5 3 experiments). At this time point,
mitochondrial TMRE uptake remained at a high level and even
increased with time (Fig. 1a).
We have previously demonstrated that exposure of cultured rat
hippocampal neurons to a high extracellular K1 concentration
(50 mM) greatly abolished the increase in TMRE uptake during
the STS exposure (Krohn et al., 1999). However, a strong plasma
membrane depolarization may inhibit the entry of TMRE into
the cytosolic compartment and may thus limit mitochondrial
TMRE uptake (Nicholls and Ward, 2000). Outward potassium
currents have been shown to mediate plasma membrane hyper-
polarization during neuronal apoptosis (Yu et al., 1996). Treat-
ment of cultured rat hippocampal neurons with selective inhibi-
tors of outward potassium currents (25 mM TEA plus 1 mM
clofilin) caused a significant decrease in cellular TMRE uptake in
control cells, suggesting that these currents are involved in the
regulation of plasma membrane potential (DCp) under physio-
logical conditions. Interestingly, staurosporine was still able to
increase TMRE uptake in cultures treated with TEA plus clofilin,
suggesting that the increase in TMRE uptake during
staurosporine-induced apoptosis was not attributable to activa-
tion of outward potassium currents and subsequent plasma mem-
brane hyperpolarization (Fig. 1b).
Mitochondrial depolarization inhibits staurosporine-
induced cytochrome c release in rat
hippocampal neurons
To address the issue regarding whether mitochondria have to
remain polarized for staurosporine-induced cytochrome c release
to occur, we treated cultured rat hippocampal neurons with the
potassium ionophore valinomycin (10 nM) or the protonophore
FCCP (10 mM). Both treatments induced a prominent mitochon-
4554 J. Neurosci., July 1, 2001, 21(13):4551–4563 Poppe et al. • Mitochondria and Apoptosis
drial depolarization, as evidenced by decreased uptake of the
voltage-sensitive probes TMRE, R123, and CMXRos into mito-
chondria (data not shown). Hippocampal neurons were exposed
to 100 nM staurosporine, valinomycin, FCCP, or a combination of
staurosporine and the ionophores. After 6 hr, cytochrome c
release was evaluated by immunofluorescence analysis. Exposure
to staurosporine induced a significant cytochrome c release, as
shown by a diffuse cytochrome c immunofluorescence compared
with vehicle-treated controls (Fig. 2). Valinomycin and FCCP
alone induced little cytochrome c release at this time point. In
contrast to cultures treated with staurosporine alone, cotreatment
with valinomycin or FCCP inhibited staurosporine-induced cyto-
chrome c release.
Staurosporine induces early mitochondrial, but not
plasma membrane hyperpolarization in D283
medulloblastoma cells
Increased uptake of TMRE was also observed in the D283 me-
dulloblastoma cells in response to 3 mM staurosporine (Fig. 3).
However, mitochondrial TMRE fluorescence may change in re-
sponse to alterations in either DCm or DCp (Nicholls and Ward,
2000). To distinguish whether the increased uptake of TMRE was
attributable to mitochondrial or plasma membrane hyperpolar-
ization, we simulated single-cell fluorescence changes in D283
medulloblastoma cells in response to alterations in either DCm or
DCp and compared these simulations with the traces we obtained
during an exposure to staurosporine. For this purpose, we used a
simulation program that is based on Nernst calculations of the
distribution of voltage-sensitive cationic probes in the extracellu-
lar, cytoplasmic, or mitochondrial compartments (Ward et al.,
2000; kindly provided by Prof. David G. Nicholls, The Buck
Institute, Novato, CA). Constants for mitochondrial volume frac-
tion, plasma membrane permeability rate for TMRE, as well as
TMRE saturation concentration were experimentally determined
as described in Materials and Methods. To validate the simula-
tion, D283 medulloblastoma cells were incubated with 10 nM
TMRE (Fig. 3a, dotted line). After equilibration of the TMRE
signal, cells were exposed to 5 mM oligomycin, which hyperpolar-
izes mitochondria. This was followed by an exposure to 2 mM
FCCP plus 5 mM oligomycin to depolarize mitochondria. The
solid line in Figure 3a shows the simulation of the experiment,
with an immediate change of DCm after addition of oligomycin
(from 2150 to 2190 mV), followed by an immediate mitochon-
drial depolarization after addition of FCCP plus oligomycin
(from 2190 to 0 mV). We next recorded TMRE traces of D283
medulloblastoma cells exposed to 3 mM staurosporine using two
different TMRE concentrations, 10 nM (Fig. 3b,c) and 100 nM
(Fig. 3d,e). After 200 min of staurosporine treatment, mitochon-
dria were depolarized by the addition of 2 mM FCCP plus 5 mM
oligomycin. The dotted lines in Figure 3 show the respective time
lapse of total cellular fluorescence in percentage of baseline after
equilibration with 10 nM (b, c) and 100 nM (d, e) TMRE. In either
case, TMRE fluorescence increased significantly after exposure
to staurosporine, and a sharp drop in TMRE fluorescence was
observed in response to FCCP plus oligomycin. Next, simulations
were calculated for each TMRE concentration with an immediate
change in either DCm (Fig. 3b,d, solid lines) (hyperpolarization
from 2150 to 2190 mV, representing the best fit) or DCp (Fig.
3c,e, solid lines) (hyperpolarization from 260 to 290 mV, repre-
senting the best fit) after addition of staurosporine. This was
followed by a simulation of the depolarization of mitochondria
from 2190 to 0 mV after addition of FCCP plus oligomycin. With
either TMRE concentration, the simulations based on DCp
changes were less convincing than those based on DCm changes.
Moreover, the peak in TMRE fluorescence occurring in 100 nM
TMRE-loaded D283 medulloblastoma cells after the addition of
FCCP plus oligomycin (“unquenching” of TMRE fluorescence)
is not well represented using the plasma membrane simulation.
Both staurosporine and valinomycin induce
cytochrome c release in human D283
medulloblastoma cells
The above data indicated that mitochondrial hyperpolarization
may precede cytochrome c release in neuronal apoptosis. How-
ever, mitochondrial depolarization has also been suggested to
trigger cytochrome c release and caspase activation in neural cells
(Wadia et al., 1998; Heiskanen et al., 1999; Luetjens et al., 2000).
We were therefore interested to investigate in more detail the
influence of DCm, overexpression of anti-apoptotic proteins (Bcl-
xL), and mitochondrial respiratory chain activity on cytochrome
c release in human D283 medulloblastoma cells. To this end,
D283 cells were exposed to staurosporine or the potassium iono-
phore valinomycin, which depolarizes mitochondria (Holmu-
hamedov et al., 1998; Rottenberg and Wu, 1998). Subcellular
fractionation experiments revealed that treatment of D283 me-
dulloblastoma cells with staurosporine (3 mM) induced a signifi-
Figure 2. Inhibition of cytochrome c re-
lease in rat hippocampal neurons by dissi-
pation of mitochondrial potassium and pro-
ton gradients. Cultured rat hippocampal
neurons were exposed to vehicle (a), 10 nM
Val ( b), 10 mM FCCP (c), 300 nM STS (d),
Val 1 STS (e), or FCCP 1 STS ( f) for 6 hr.
Distribution of cytochrome c is shown by
immunofluorescence analysis. Only cultures
exposed to 300 nM STS showed a diffuse
cytochrome c staining pattern (d). Scale
bar, 50 mm.
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cant release of cytochrome c from mitochondria into the cytosol
already after 4 hr of treatment. The appearance of cytochrome c
in the cytosolic fraction was associated with a corresponding
decrease in the mitochondria-containing nuclear–heavy mem-
brane fraction (Fig. 4a). Exposure to valinomycin (10 mM) also
induced a release of cytochrome c into the cytosol after 6 and 16
hr of exposure (Fig. 4b), albeit the magnitude of this release was
smaller. As with staurosporine, the increased accumulation of
cytochrome c in the cytosol was associated with a corresponding
decrease in the cytochrome c content of the mitochondria-
containing nuclear–heavy membrane fraction.
Immunoblot analysis of whole-cell lysates exposed to stauro-
sporine for 8 hr showed a reduction in total cytochrome c content
compared with vehicle-treated control cells (Fig. 4c), likely be-
cause of the reported degradation of cytochrome c during apo-
ptosis (Bobba et al., 1999). In contrast, exposure to valinomycin
for 6 hr did not alter total cellular cytochrome c content. Inter-
estingly, prolonged exposure to valinomycin (16 hr) increased
cytochrome c content, presumably a consequence of increased
cytochrome c transcription during conditions of metabolic stress
(Dey and Moraes, 2000).
Overexpression of Bcl-xL inhibits staurosporine-
induced mitochondrial hyperpolarization and
cytochrome c release
To relate cytochrome c release with changes in DCm during
apoptosis, we performed experiments using the voltage-sensitive
probe CMXRos in combination with immunofluorescence mi-
croscopy. Controls treated with vehicle and loaded with
CMXRos showed a rod-like staining pattern characteristic of
mitochondria (Fig. 5a). In these cells, CMXRos fluorescence
colocalized with cytochrome c immunofluorescence (Fig. 5c). In
agreement with our TMRE confocal imaging studies, cultures
exposed to staurosporine showed an increased CMXRos uptake
after 30 min of treatment (Fig. 5a,b). At this time, cytochrome c
was still localized to mitochondria (Fig. 5d). Interestingly, cyto-
chrome c immunofluorescence concentrated around the nucleus,
indicative of perinuclear clustering of mitochondria early during
apoptosis (De Vos et al., 1998). Quantification of CMXRos (Fig.
5e) as well as TMRE (Fig. 5f) fluorescence in cell lysates con-
firmed the increased uptake of voltage-sensitive probes during
staurosporine-induced apoptosis and demonstrated that the in-
crease in CMXRos and TMRE fluorescence was not an artifact
caused by staurosporine-induced morphological alterations.
The ability of the anti-apoptotic protein Bcl-xL to inhibit
staurosporine-induced mitochondrial hyperpolarization and cy-
tochrome c release was investigated in human D283 medulloblas-
Figure 3. Effect of oligomycin (a) and STS (b–e) on cellular TMRE
uptake in D283 medulloblastoma cells and simulation of TMRE fluores-
cence changes according to Ward et al. (2000). The dotted lines represent
the time lapse of total cellular fluorescence in percentage of baseline after
equilibration with 10 nM (a–c) or 100 nM (d, e) TMRE. After equilibration
of the TMRE signal, cells were exposed to 5 mM oligomycin (a) or 3 mM
STS (b–e). The onset of treatment is indicated by the arrows on the lef t.
After the respective treatments, mitochondria were depolarized by the
addition of 2 mM FCCP plus 5 mM oligomycin (arrows on the right).
Simulations based on the Nernst equation were calculated with immediate
changes in DCM (solid lines in a, b, and d; lef t arrow, hyperpolarization
from 2150 to 2190 mV) or DCP (solid lines in c and e; lef t arrow,
hyperpolarization from 260 to 290 mV). In each case, this was followed
by a simulation of mitochondrial depolarization after addition of FCCP
plus oligomycin (right arrows, depolarization from 2190 to 0 mV). Note
that the time lapse of the oligomycin and STS treatments have the same
shape. Simulations based on changes in DCP are less convincing, and the
peak after FCCP plus oligomycin in cells loaded with 100 nM TMRE in
d does not occur in e (solid lines). Traces are means from all cells within
the microscope field in a typical experiment (n 5 18–26 cells). The
experiments were performed in duplicate (10 nM TMRE experiments)
and triplicate (100 nM TMRE experiment) with similar results.
Figure 4. Cytochrome c release induced by staurosporine and valinomy-
cin in human medulloblastoma D283 cells. Cultures were incubated for
the indicated periods of time with staurosporine (STS) ( a), valinomycin
(Val ) (b), or the vehicle. Cells were fractionated into a cytosolic and a
mitochondria-containing nuclear–heavy membrane fraction (Pellet). Im-
munoblot analysis was performed using an anti-cytochrome c antibody.
Blots were incubated with an anti-VDAC antibody to exclude contami-
nations of the cytosolic fraction with mitochondria. An anti-a-tubulin
antibody was used as loading control. The experiment was repeated three
times with similar results. c, Immunoblot analysis of whole-cell lysates
using an anti-cytochrome c and an anti-a-tubulin antibody after exposure
to STS, Val, or vehicle for the indicated periods of time. The experiment
was repeated twice with similar results.
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toma cells stably transfected with plasmid pSFFV-Neo-Bcl-xL
(D283/Bcl-xL) or empty vector pSFFV-Neo (D283/neo). Overex-
pression of Bcl-xL in D283/Bcl-xL cells was confirmed by Western
blot analysis (Fig. 5f, inset). We observed decreased CMXRos
uptake in Bcl-xL-overexpressing cells under control conditions.
This was not observed in TMRE-loaded cells, suggesting that
CMXRos does not solely report membrane potential changes.
Interestingly, the staurosporine-induced increase in CMXRos
and TMRE uptake was significantly inhibited in Bcl-xL-
overexpressing cultures (Fig. 5e,f).
After 3 hr of exposure, cytochrome c was released from mito-
chondria in the majority of D283/neo cells, resulting in a weak,
diffuse cytochrome c staining in the cytosol (Fig. 5g,h). In cells
overexpressing Bcl-xL, staurosporine-induced cytochrome c re-
lease was significantly inhibited (Fig. 5i,j). However, overexpres-
sion of Bcl-xL did not prevent the perinuclear clustering of
mitochondria during apoptosis. Bcl-xL overexpression also signif-
icantly inhibited staurosporine-induced caspase-3 like protease
activity (Fig. 5k) determined in cytosolic extracts by measuring
the cleavage of Ac-DEVD-AMC, a fluorigenic substrate prefer-
entially cleaved by caspase-3, -7, and -8, but also by caspase-1, -6,
-9, and -10. Moreover, Bcl-xL significantly inhibited the
staurosporine-induced decrease in cell viability determined by
staining of cultures with calcein AM and EthD-1 (Fig. 5l).
EthD-1 is a DNA binding dye that enters dead cells through
damaged membranes and thus indicates (secondary) necrosis.
Bcl-xL overexpression does not inhibit valinomycin-
induced cytochrome c release and
mitochondrial depolarization
D283 medulloblastoma cells exposed to valinomycin showed a
dramatically altered CMXRos uptake (Fig. 6a,b) (15 min of
exposure). Mitochondria failed to accumulate CMXRos, and
instead the entire cell was diffusely stained. The increased
uptake of CMXRos into the cytosolic compartment is likely
attributable to plasma membrane hyperpolarization occurring
additionally at micromolar concentrations of valinomycin
4
sion of Bcl-xL was confirmed by immunoblotting using an anti-Bcl-x
antibody ( f, inset). e, Quantification of CMXRos fluorescence in D283/
Neo cultures confirmed an early increase in CMXRos uptake after the
exposure to STS. In contrast, the increase of CMXRos uptake was
inhibited in D283/Bcl-xL cells. Data are means 6 SEM from n 5 8
cultures; *p , 0.05 with respect to control. Experiment was performed in
triplicate and yielded comparable results. f, Quantification of TMRE
uptake in D283/Neo cultures confirmed the early increase of fluorescence
obtained with CMXRos. The increase of TMRE uptake was inhibited in
D283/Bcl-xL cells. Data are means 6 SEM from n 5 8 cultures; *p , 0.05
with respect to control. Experiment was repeated twice with comparable
results. g–j, Cytochrome c distribution was visualized by immunofluores-
cence analysis after 3 hr exposure to STS or vehicle. Note that the
STS-induced cytochrome c release was significantly reduced in D283/
Bcl-xL cells ( j) compared with D283/SFFV cells (h). Scale bar, 10 mm (g).
k, Control cells and Bcl-xL-overexpressing cells were treated with vehicle
(Con) or STS for 4 and 6 hr. Caspase-3-like protease activity was mea-
sured by cleavage of the fluorigenic substrate Ac-DEVD-AMC. Activities
are presented as increase in AMC fluorescence (in arbitrary fluorescence
units) over 60 min per microgram of protein. Data are means 6 SEM
from n 5 8 cultures. The experiment was repeated three times with
similar results. Different from controls, *p , 0.05. l, Quantification of cell
death after exposure to STS. D283 cells were incubated with STS or
vehicle for up to 24 hr. Cells were stained simultaneously with 1 mM
calcein AM and 2 mM ethidium homodimer (EthD-1). Live (green) and
dead (red) cells were counted. n 5 4 cultures (430–3000 cells) per time
point. Different from controls, *p , 0.05.
Figure 5. Overexpression of Bcl-xL inhibits staurosporine-induced mito-
chondrial hyperpolarization and cytochrome c release. a–d, D283 cells
were exposed to vehicle or STS. After 30 min exposure to STS, cyto-
chrome c immunofluorescence remained mitochondrial (d), whereas
CMXRos uptake increased significantly (b). Scale bar, 10 mm. Experi-
ments were performed three times with comparable results. e–l, D283
medulloblastoma cells were stably transfected with pSFFV-Neo-Bcl-xL
(D283/Bcl-xL) or empty plasmid pSFFV-Neo (D283/Neo). Overexpres-
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(Holmuhamedov et al., 1998; Rottenberg and Wu, 1998). An
immediate mitochondrial depolarization after addition of va-
linomycin was also observed using the probes TMRE and R123
(data not shown). After 15 min exposure to valinomycin,
cytochrome c was retained in mitochondria (Fig. 6c,d). To test
whether valinomycin, like staurosporine, was toxic to D283
cells, the effect of valinomycin on viability of D283 cells was
determined by simultaneous staining of cultures with calcein
AM and EthD-1. Exposure to valinomycin for 24 hr induced a
significant increase in the number of EthD-1-positive cells.
Interestingly, overexpression of Bcl-xL failed to provide a
significant protection against valinomycin-induced cell death
(Fig. 6e). Moreover, overexpression of Bcl-xL did not influence
the valinomycin-induced loss of cytochrome c (Fig. 6f,h,j,l ).
The decreased CMXRos uptake into mitochondria induced by
valinomycin was also not prevented in Bcl-xL-overexpressing
cells (Fig. 6g,i,k ,m).
High magnification of cytochrome c immunofluorescence re-
vealed that exposure to valinomycin induced mitochondrial alter-
ations indicative of mitochondrial swelling (Fig. 6n,o). These
alterations were not sensitive to overexpression of Bcl-xL (Fig.
6p). Mitochondrial swelling in response to valinomycin could be
more clearly detected in rat primary astrocytes (Fig. 6q,r). The
low density of mitochondria in the somata of astrocytes allowed a
quantification of mitochondrial swelling after a 6 hr exposure to
10 mM valinomycin. Measurement of the mitochondrial area using
Figure 6. Overexpression of Bcl-xL does
not inhibit valinomycin-induced mitochon-
drial depolarization and cytochrome c re-
lease. a–d, Representative images of
vehicle-treated (a, c) and Val-treated (b, d)
D283 medulloblastoma cells fixed after 15
min of exposure. a, b, Changes of mito-
chondrial membrane potential were deter-
mined by CMXRos uptake. Note that the
mitochondrial staining pattern was lost af-
ter treatment with Val (b). c, d, Distribu-
tion of cytochrome c was determined by
immunofluorescence analysis. Cytochrome
c immunofluorescence remained intact af-
ter exposure to Val (d). Scale bar, 10 mm. e,
Quantification of cell death after exposure
to Val. D283/Neo and D283/Bcl-xL cells
were exposed to vehicle or Val for 12 and
24 hr and stained simultaneously with 1 mM
calcein AM and 2 mM ethidium ho-
modimer. The percentage of dead cells was
determined. n 5 4 cultures (600–3000 cells)
per time point. Different from controls,
*p , 0.05. n.s., Not statistically significant.
f–m, Cells were treated with Val or vehicle
for 6 hr. Cytochrome c distribution was
visualized by immunofluorescence analysis.
Val-induced cytochrome c release was not
inhibited in Bcl-xL-overexpressing cells (l,
arrowheads) compared with control cells
(h). Mitochondria appeared swollen in con-
trol and Bcl-xL-overexpressing cells (h, l;
arrows). Overexpression of Bcl-xL could
also not inhibit loss of mitochondrial mem-
brane potential (i, m). Scale bar (in f ): f–m,
10 mm. n–p, High magnification of mito-
chondria and mitochondria-rich regions in
vehicle- and Val-treated cultures (6 hr)
stained with the cytochrome c antibody.
Overexpression of Bcl-xL does not inhibit
large-scale mitochondrial swelling induced
by Val. Mitochondria of vehicle-treated
D283/Neo and D283/Bcl-xL cells were in-
distinguishable, therefore only mitochon-
dria of a D283/Bcl-xL cell are shown. Im-
ages were deconvoluted using No Neighbor
Deblurring software, which applies the al-
gorithm of Monck et al. (1992) to reduce
image background haze attributable to
light originating from unsharp areas of the
specimen. Scale bar (in n): n–p; 5 mm. N,
Nucleus. All experiments were repeated
twice with comparable results. q–r, Images
of mitochondria in vehicle- and Val-treated
(6 hr) rat primary astrocytes stained with the
anti-cytochrome c antibody. Images were
deconvoluted using the above-mentioned
software. Scale bar, 5 mm (q).
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Metamorph software revealed a mean increase of 209 6 80%
compared with vehicle-treated controls (n 5 50 and 75 mitochon-
dria, respectively; p , 0.05).
Valinomycin-induced cytochrome c release occurs
without significant activation of the caspase cascade
We next compared the effects of valinomycin and staurosporine
on caspase activation in D283 medulloblastoma cells. Caspase-3-
like protease activity determined by measuring the cleavage of
Ac-DEVD-AMC after exposure to 10 mM valinomycin was not
significantly different from control cultures treated with the vehi-
cle at all time points investigated (Fig. 7a). Cleavage of z-IETD-
AFC and Ac-LEHD-AMC (substrates for caspase-6, -8, -9 and
-10), and z-VDVAD-AFC (a substrate for caspase-2 and -3) did
also not increase after exposure to valinomycin (data not shown).
In contrast, cultures treated with staurosporine showed significant
caspase-3-like protease activity after 6 hr of treatment (Fig. 7a).
Lack of caspase-3 activation was also confirmed by immunoblot
analysis. Caspase-3 is proteolytically activated by cleavage of its
precursor pro-caspase-3 (32 kDa) into active subunits.
Staurosporine-treated cultures accumulated the active caspase-3
subunit (p17) after 6 hr of treatment (Fig. 7b). In contrast, active
caspase-3 could not be detected in cultures treated with valino-
mycin for 6 hr (Fig. 7b). Similar results were obtained in cultures
treated for 24 hr with valinomycin (data not shown). Chromatin
condensation and fragmentation are considered to be one of the
hallmarks of apoptotic cells. To observe nuclear changes, D283
cells were stained with the chromatin-specific dye Hoechst 33258.
Exposure to valinomycin for 20 hr induced little chromatin con-
densation or fragmentation (Fig. 7c–e). In contrast, nuclei of cells
treated with 3 mM staurosporine for 6 hr showed a prominent
apoptotic morphology (Fig. 7e). Interestingly, the toxicity of va-
linomycin was associated with the appearance of multiple cyto-
plasmic vacuoles, but cell shrinkage was not observed (data not
shown). Therefore, valinomycin induced a necrotic, rather than
apoptotic cell death in D283 medulloblastoma cells.
Exposure to valinomycin inhibits staurosporine-
induced mitochondrial hyperpolarization and
cytochrome c release
Similar to the results obtained with TMRE and CMXRos (Figs.
4, 5), mitochondria of staurosporine-treated cells accumulated
more R123 fluorescence compared with vehicle-treated controls
(Fig. 8a,b). In contrast, cells treated with valinomycin failed to
accumulate significant amounts of R123 in their mitochondria
(Fig. 8c). Of note, the combined exposure to staurosporine and
valinomycin reversed the increase in R123 uptake induced by
staurosporine (Fig. 8d). This effect was independent of the con-
centration of R123 used, because similar uptake patterns were
observed in cultures incubated with 100 nM, 300 nM, or 2 mM
R123. Moreover, this effect was independent of the probe used,
Figure 7. Valinomycin does not activate neural apoptosis. a, D283 me-
dulloblastoma cells were treated with vehicle (Con), Val, or STS for up to
24 hr. Caspase-3 like activity was measured by cleavage of the fluorigenic
substrate Ac-DEVD-AMC. Activities are presented as increase in AMC
fluorescence (in arbitrary fluorescence units) over 60 min per microgram
of protein. Data are means 6 SEM from n 5 8 cultures, and experiments
were repeated three times with similar results. Different from controls,
*p , 0.05. b, Immunoblot probed with an antibody recognizing
procaspase-3 and active caspase-3. Cultures were exposed to vehicle
(Con), Val, and STS for 6 hr. Experiment was repeated twice with similar
results. c–e, Hoechst staining of D283 cells treated with vehicle (c) or Val
(d) for 20 hr. Exposure to Val induced no chromatin condensation in
contrast to cells treated with STS for 6 hr ( e). Scale bar, 50 mm.
Figure 8. Valinomycin inhibits staurosporine-induced hyperpolarization
and cytochrome c release. a–d, Cultures were exposed for 30 min to
vehicle (Con) (a), STS (b), Val ( c), or to a combination of STS and Val
(d), loaded with 2 mM R123 for 30 min and washed with HBS. STS
induced an increased uptake of R123 into mitochondria (b), whereas
treatment with Val decreased R123 uptake into mitochondria (c). Com-
bined exposure to STS and Val reduced the STS-induced increase in R123
uptake (d). Scale bar, 25 mm. Experiments were repeated four times with
comparable results. e, Cultures were incubated for 4 hr with vehicle, Val,
STS, or a combination of Val and STS. Cells were fractionated into a
cytosolic and a mitochondria-containing nuclear–heavy membrane frac-
tion (Pellet). Immunoblot analysis of cytosolic fractions was performed
using an anti-cytochrome c antibody. Blots were incubated with an anti-
VDAC antibody to exclude contaminations of the cytosolic fractions with
mitochondria and with an anti-a-tubulin antibody to confirm equal load-
ing of each sample. Control pellet of vehicle-treated cells is shown. The
experiment was performed in triplicate and yielded comparable results.
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because the staurosporine-induced increase in TMRE or
CMXRos uptake was also inhibited in cultures treated with
valinomycin (data not shown).
To examine the effect of valinomycin-induced mitochondrial
depolarization on staurosporine-induced cytochrome c release,
we performed an immunoblot analysis of cytosolic fractions of
D283 medulloblastoma cells treated for 4 hr with staurosporine (3
mM) or valinomycin (10 mM). Exposure to staurosporine or vali-
nomycin alone showed a significant release of cytochrome c into
the cytosol after both treatments (Fig. 8e), thus confirming our
previous immunofluorescence and immunoblot observations
(Figs. 4–6). Interestingly, in cultures treated simultaneously with
valinomycin and staurosporine, release of cytochrome c was sig-
nificantly decreased. Similar results were obtained in cells ana-
lyzed by cytochrome c immunofluorescence microscopy (data not
shown).
Valinomycin inhibits staurosporine-induced
cytochrome c release in MCF-7/Casp-3 cells
transfected with cytochrome c–EGFP
The results obtained in D283 medulloblastoma cells confirmed
our previous observation of an inhibition of staurosporine-
induced cytochrome c release by valinomycin or FCCP in cul-
tured rat hippocampal neurons. The interaction of staurosporine
and valinomycin was further investigated in MCF-7/Casp-3 cells
stably transfected with cytochrome c–EGFP. Cells exposed to
vehicle for 6 hr maintained their mitochondrial cytochrome
c–EGFP fluorescence (Fig. 9a,e). As reported previously (Heis-
kanen et al., 1999), exposure to 3 mM staurosporine induced a
significant release of cytochrome c–EGFP from mitochondria,
resulting in a diffuse staining of the cytosol and the nucleus (Fig.
9b,f). Six hours of exposure to 10 mM valinomycin induced prom-
inent mitochondrial swelling, and the cytochrome c–EGFP signal
was diffuse in a subpopulation of the cells (Fig. 9c,g). Of note,
exposure to valinomycin greatly inhibited cytochrome c–EGFP
release induced by staurosporine because mitochondrial cyto-
chrome c signal was still clearly visible after 6 hr (Fig. 9d,h).
Dissipation of mitochondrial potassium and proton
gradients inhibits staurosporine-induced activation of
the caspase cascade
We next examined the ability of valinomycin to inhibit the acti-
vation of the caspase cascade in staurosporine-exposed D283
cells. After 6 hr treatment with 3 mM staurosporine, caspase
cleavage activity increased significantly in the cultures (Fig. 10a).
In cultures treated simultaneously with staurosporine and valino-
mycin, DEVD-cleavage was significantly reduced (Fig. 10a). This
result was confirmed by immunoblot analysis using an anti-
caspase-3 antibody (Fig. 10b). The staurosporine-induced appear-
ance of the active p17 subunit was significantly reduced in cul-
tures treated simultaneously with valinomycin. Cultures exposed
to staurosporine plus valinomycin also demonstrated a significant
decrease in the percentage of apoptotic nuclei compared with
cultures exposed to staurosporine alone (Fig. 10c). FCCP also
inhibited staurosporine-induced caspase-3-like protease activity
shown by the reduced cleavage of the Ac-DEVD-AMC substrate
(Fig. 10d). Finally, cellular ATP levels were determined in D283
cells after exposure to staurosporine and valinomycin. Treatment
with either staurosporine or valinomycin induced a decrease in
cellular ATP levels. However, there was no difference in the
reduction of cellular ATP levels between staurosporine-treated
cultures and cultures treated simultaneously with staurosporine
and valinomycin (Fig. 10e). Moreover, the ability of valinomycin
to inhibit staurosporine-induced caspase-3-like protease activity
was preserved in D283 r2 cells deficient in mitochondrial respi-
ration (51 6 5% decrease in DEVDase activity after 8 hr of
treatment; n 5 8 cultures; p , 0.05).
DISCUSSION
One proposed mechanism for apoptosis induction by trophic
factor withdrawal, UV irradiation, or staurosporine exposure is a
disturbance of mitochondrial ion and volume homeostasis, with
several theories arguing for mitochondrial depolarization, hyper-
polarization, swelling, or shrinkage (Nieminen et al., 1996; White
and Reynolds, 1996; Bossy-Wetzel et al., 1998; Wadia et al., 1998;
Yoshida et al., 1998; Heiskanen et al., 1999; Krohn et al., 1999;
Stefanis et al., 1999; Deshmukh et al., 2000; Goldstein et al., 2000;
Luetjens et al., 2000; Matsuyama et al., 2000). We observed an
increased uptake of the voltage-sensitive probes TMRE, R123,
and CMXRos into mitochondria during staurosporine-induced
apoptosis of rat hippocampal neurons and human D283 medul-
loblastoma cells that occurred before cytochrome c release and
caspase activation. Increased uptake of voltage-sensitive probes
could be detected using dyes that are taken up reversibly or
irreversibly by mitochondria. However, the Nernstian behavior of
these probes predicts an increase in uptake as either DCm or DCp
increases (Nicholls and Ward, 2000). Moreover, increased uptake
of voltage-sensitive probes during apoptosis could be caused by
an increase in mitochondrial matrix volume (Vander Heiden et
al., 1997; Buckman et al., 2001).
To distinguish between increases in DCm and DCp as a cause
for the increased TMRE uptake during staurosporine-induced
apoptosis, we have remodelled changes in cellular TMRE fluores-
Figure 9. Valinomycin induces mitochondrial
swelling and inhibits staurosporine induced cy-
tochrome c release in MCF-7/Casp-3 cells sta-
bly transfected with cytochrome c–EGFP. Cul-
tures were treated with vehicle (Con; a, e), STS
(b, f ), Val (c, g), and STS and Val in combina-
tion (d, h). Digital images were acquired before
(a–d) and 6 hr after (e–h) treatment. Exposure
to STS induced a significant cytochrome c re-
lease resulting in a diffuse staining of cyto-
plasm and nucleus ( f ). Val alone induced cy-
tochrome c release (arrowheads), as well as
mitochondrial swelling (arrows) (g). Exposure
to Val inhibited STS-induced cytochrome c
release (h). Scale bar, 10 mm. Experiments
were repeated six times with similar results.
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cence based on Nernst calculations of TMRE fluorescence distri-
bution in the extracellular, cytoplasmic, and mitochondrial com-
partment (Ward et al., 2000). Simulation of single-cell fluorescence
changes demonstrated that the staurosporine-induced increase in
TMRE fluorescence could be precisely remodelled by increasing
DCm, but not DCp. However, it should be noted that the simula-
tion of plasma membrane hyperpolarization in a “virtual” cell
produced traces that were not identical, but similar in shape to
those recorded after addition of staurosporine, or obtained with
the simulation of mitochondrial membrane hyperpolarization (Fig.
3). This indicates that simple quantifications of fluorescence of
membrane potential probes should be interpreted with caution (see
also Ward et al., 2000). It has been reported that apoptosis of
mouse neocortical neurons induced by staurosporine is associated
with plasma membrane hyperpolarization because of the enhance-
ment of a delayed rectifier IK current (Yu et al., 1996). In the latter
study, however, plasma membrane hyperpolarization became evi-
dent only 9–11 hr after addition of staurosporine, and the IK
current actually tended to decrease during the early stage of apo-
ptosis (30 min after onset of the staurosporine treatment). Two
other lines of evidence suggest that the increased mitochondrial
uptake of voltage-sensitive probes during apoptosis was indeed
caused by mitochondrial membrane hyperpolarization: (1) Block-
ing of outward potassium currents did not inhibit staurosporine-
induced hyperpolarization. (2) The staurosporine-induced in-
crease in TMRE and CMXRos uptake was inhibited in cells
overexpressing Bcl-xL, an anti-apoptotic protein with a mainly
mitochondrial site of action (Vander Heiden et al., 1997).
It is possible that the mitochondrial hyperpolarization observed
during the early stage of staurosporine-induced apoptosis is caused
by a Ca21-dependent stimulation of mitochondrial energetics.
Staurosporine induces a Ca21-dependent cell death in neurons
(Prehn et al., 1997), and cytosolic and mitochondrial Ca21 over-
loading have been detected early during staurosporine-induced
apoptosis (Kruman and Mattson, 1999). Mitochondrial Ca21 up-
take is known to stimulate the activity of several NADH-producing
dehydrogenases of the mitochondrial matrix and could thereby
increase the mitochondrial proton motive force. However, because
this is a physiological, regulated process, it is likely that other
mechanisms operate in cells undergoing stress-induced apoptosis.
One potential mechanism that could cause a pathophysiological
increase in DCm is a shift from state 3 to state 4 respiration during
apoptosis. This could be achieved by inhibiting mitochondrial
ADP–ATP exchange (Vander Heiden et al., 1999).
Interestingly, dissipation of mitochondrial potassium or proton
gradients by valinomycin or FCCP not only inhibited mitochon-
drial hyperpolarization, but also staurosporine-induced cyto-
chrome c release. The inhibitory effect of valinomycin on
staurosporine-induced cytochrome c release (or vice versa) was
confirmed in three cell types using three independent techniques.
It has been demonstrated that sufficient ATP levels are required to
trigger apoptosis, in particular the activation of the caspase cascade
(Eguchi et al., 1997; Leist et al., 1997; Lee and Shacter, 1999).
Valinomycin depolarizes mitochondria and thereby reduces mito-
chondrial ATP production. However, the inhibitory effect of vali-
nomycin on apoptosis occurred upstream of the caspase cascade,
i.e., at the level of mitochondrial cytochrome c release. Moreover,
measurements of cellular ATP revealed that the inhibitory effect of
valinomycin on staurosporine-induced cytochrome c release was
not attributable to a reduction of cellular ATP content. Further-
more, the ability of valinomycin to inhibit staurosporine-induced
caspase-3-like protease activity was preserved in D283 r2 cells
Figure 10. Valinomycin reduces stauro-
sporine-induced increase in caspase-3 like
protease activity and apoptotic nuclear
morphology. a, Apoptotic cell death was
induced in D283 cells by an exposure to
STS for 6 hr. Val or vehicle was added
as indicated. Caspase-3 like protease ac-
tivity was measured by cleavage of the
Ac-DEVD-AMC substrate. Activities
are represented as increase in AMC fluo-
rescence over 60 min per microgram of
protein. Val significantly reduced STS-
induced Ac-DEVD-AMC cleavage. Data
are means from n 5 8 cultures; experi-
ment was repeated twice with comparable
results, *p , 0.05 different from controls.
b, Immunoblot analysis of cultures treated
with STS, Val, STS 1 Val or vehicle for 6
hr using an anti-caspase-3 antibody. Addi-
tion of Val to cultures treated with STS
reduced cleavage of pro-caspase-3 com-
pared with cultures treated with STS
alone. Experiment was repeated twice
with similar results. c, D283 cells were
exposed to STS for 4 hr. Morphology of
nuclei was visualized by Hoechst 33258
staining. Percentage of nuclei with frag-
mented chromatin was determined. n 5 4
cultures (700–800 nuclei). Different from
controls, *p , 0.05. d, Cell death was
induced by exposure to STS for 6 hr. Ve-
hicle or FCCP were added as indicated.
Caspase-3 like activity was measured by cleavage of the Ac-DEVD-AMC substrate. Data are means from n 5 8 cultures; experiments were done in duplicate
and yielded similar results, *p , 0.05 different from controls. e, Determination of cellular ATP content in D283 cells exposed to vehicle, STS, Val, or
STS 1 Val for 3 and 6 hr. Luciferase activity of cultures treated with vehicle was set to 100% activity. Treatment with STS, Val, and STS 1 Val resulted
in a decrease in luciferase activity. Data are means from n 5 4–6 cultures per treatment.
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deficient in mitochondrial respiration. Valinomycin also induces
plasma membrane hyperpolarization at micromolar concentra-
tions, as well as cytosolic acidification (Furlong et al., 1998; Hol-
muhamedov et al., 1998; Rottenberg and Wu, 1998). Both pro-
cesses should promote, rather than inhibit apoptosis (Yu et al.,
1996; Matsuyama et al., 2000).
It is therefore conceivable that valinomycin inhibited cyto-
chrome c release and apoptosis activation by inducing mitochon-
drial depolarization or by counteracting a mitochondrial ion–
volume homeostasis disregulation during staurosporine-induced
apoptosis. Valinomycin and FCCP dissipate DCm. However, the
proton gradient across the inner mitochondrial membrane can be
maintained in the presence of valinomycin and can increase signif-
icantly. Our findings therefore suggest that an electrical gradient
across the inner membrane is required for apoptotic signaling or
that the protonmotive force must be of a certain threshold. A
mitochondrial membrane potential may be required for the inser-
tion of pro-apoptotic proteins that trigger the release of cyto-
chrome c. Depolarization of the mitochondrial membrane could
also inhibit cytochrome c release by reducing Ca21 influx into the
matrix via the mitochondrial Ca21 uniporter (Nicholls and Aker-
man, 1982; Murphy et al., 1996; Andreyev et al., 1998). In primary
neuron cultures exposed to glutamate receptor agonists, mitochon-
drial depolarization has been shown to inhibit mitochondrial Ca21
overloading, free radical production, and cell death (Castilho et al.,
1998; Sengpiel et al., 1998; Stout et al., 1998).
It has also been suggested that cytochrome c release during
apoptosis could be triggered by mitochondrial swelling and a sub-
sequent rupture of the outer mitochondrial membrane (Vander
Heiden et al., 1997). Large-scale mitochondrial swelling could not
be detected in D283 cells treated with staurosporine. Moreover,
valinomycin per se induced a prominent swelling of mitochondria
but inhibited staurosporine-induced cytochrome c release. Previ-
ous studies have shown that mitochondria do not enlarge during
apoptosis (Bossy-Wetzel et al., 1998; Kluck et al., 1999; Matsuyama
et al., 2000; Scarlett et al., 2000), but may actually condense (Kluck
et al., 1999; Martinou et al., 1999). Mitochondrial condensation
could facilitate cytochrome c release, e.g., by loosening outer–inner
membrane contact sites. However, it remains to be shown whether
changes in mitochondrial morphology play an active role in cyto-
chrome c release during apoptosis.
Exposure of human medulloblastoma D283 cells to the
potassium-ionophore valinomycin caused significant cytochrome c
release from mitochondria. In contrast to staurosporine, valinomy-
cin decreased DCm, induced mitochondrial swelling, and the sub-
sequent cell death was necrotic rather than apoptotic. No caspase
activity was detectable, and overexpression of Bcl-xL failed to
reverse valinomycin-induced mitochondrial alterations. The
valinomycin-induced cytochrome c release may be secondary to
mitochondrial matrix swelling. Of note, our data suggest that
mitochondria have to swell significantly and over a prolonged
period of time to physically release their cytochrome c (Minami-
kawa et al., 1999). Valinomycin triggers mitochondrial swelling by
selectively increasing the transport of potassium ions into the
mitochondrial matrix, which then triggers the influx of anions and
water. Several groups have reported that valinomycin induces PTP
opening (Furlong et al., 1998; Dallaporta et al., 1999). However, it
should be noted that the mechanism of valinomycin-induced mi-
tochondrial swelling may be different from that induced by a
Ca21-induced PTP. Moreover, a Ca21-induced PTP could be
sensitive to Bcl-xL overexpression (Marzo et al., 1998).
In conclusion, the present study suggests the existence of two
mechanisms of mitochondrial cytochrome c release during stress-
induced cell death: (1) passive cytochrome c release secondary to
strong mitochondrial depolarization and matrix swelling that is not
inhibited by Bcl-xL overexpression and that predominantly leads to
cell necrosis and (2) active cytochrome c release that is inhibited by
Bcl-xL overexpression as well as by a dissipation of mitochondrial
potassium and proton gradients.
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